Drug
Tasurgratinib
Tasurgratinib: highest development phase Phase 1, developed by Eisai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Eisai
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tasurgratinib NCT04271488 | Phase 1 | Hepatic Impairment |
Latest
No recent events.
Follow Tasurgratinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.